Benjamin N Breyer, MD
Urology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 23 years
- University of Chicago, Pritzker School of Medicine, 2003
Offices
2 locations · UCSF Medical Group Business Services · University of California San Francisco
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Breyer’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A91487 · Current
Licensed to practise in California · since 2005 · expires 2028-11-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Urology - Urology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$130,469
Medicare paid this office $130,469 for 413 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 194 | $19,675 | $81 |
| Insertion of inflatable urethra or bladder neck sphincter | 17 | $11,675 | $687 |
| New patient visit (45+ min) | 94 | $10,065 | $107 |
| Insertion of multicomponent inflatable penile implant | 13 | $8,714 | $670 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $5,681 | $62 |
See all 20 services
| Return visit (30+ min) | 194 | $19,675 | $81 |
| Insertion of inflatable urethra or bladder neck sphincter | 17 | $11,675 | $687 |
| New patient visit (45+ min) | 94 | $10,065 | $107 |
| Insertion of multicomponent inflatable penile implant | 13 | $8,714 | $670 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $5,681 | $62 |
| Long return visit (40+ min) | 33 | $4,668 | $130 |
| Short return visit (20+ min) | 72 | $4,611 | $52 |
| Incision of urethra using an endoscope | 19 | $4,560 | $217 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 216 | $4,115 | $15 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 13 | $1,416 | $109 |
| New patient visit (30+ min) | 21 | $1,232 | $59 |
| Injection procedure through bladder and urethra for x-ray imaging | 28 | $1,202 | $43 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $626 | $7 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $448 | $34 |
| Review by radiologist of urinary bladder and urethra images with contrast | 26 | $348 | $13 |
| Injection procedure for imaging of bladder during voiding | 14 | $282 | $20 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 16 | $223 | $14 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $209 | $16 |
| Electronic assessment of bladder emptying | 11 | $62 | $5 |
| Simple timed assessment of bladder emptying | 16 | $61 | $4 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of bladder and urethra using an endoscope | 171 | 136 | 180 | 140 | 132 | 92 |
| Injection procedure through bladder and urethra for x-ray imaging | 44 | 30 | 33 | 33 | 21 | 28 |
| Insertion of inflatable urethra or bladder neck sphincter | 14 | 20 | 19 | 20 | 25 | 17 |
| Injection procedure for imaging of bladder during voiding | 26 | 30 | 25 | – | 12 | 14 |
| Incision of urethra using an endoscope | 14 | – | 17 | 14 | 24 | 21 |
| Biopsy of prostate gland | 19 | 18 | 26 | 24 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
413 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 8% · Also on Medicaid 17% · Health risk score 1.49. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Cancer 60% · Coronary heart disease 36% · Diabetes 30% · Chronic kidney disease 26% · Atrial fibrillation 25% · Depression 22% · Heart failure 14% · COPD 12% · Stroke 8% · Dementia 6%.
The office billed $1,147,358, Medicare allowed $169,103 and paid $130,469; for 1,283 services of 83 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 413 | 1,283 | 74 | 1.49 | $1,147,358 | $130,469 |
| 2023 | 485 | 1,060 | 74 | 1.57 | $1,174,092 | $147,990 |
| 2022 | 486 | 1,065 | 74 | 1.41 | $1,123,115 | $138,903 |
| 2021 | 571 | 1,320 | 73 | 1.59 | $1,354,692 | $172,741 |
| 2020 | 510 | 1,131 | 73 | 1.62 | $1,226,568 | $151,715 |
| 2019 | 507 | 1,105 | 73 | 1.69 | $1,012,893 | $120,870 |
| 2018 | 494 | 1,314 | 72 | 1.70 | $1,242,220 | $143,969 |
| 2017 | 535 | 1,410 | 72 | 1.62 | $1,306,670 | $148,370 |
| 2016 | 581 | 1,537 | 72 | 1.51 | $1,326,114 | $153,008 |
| 2015 | 482 | 1,441 | 72 | 1.42 | $1,294,675 | $151,841 |
| 2014 | 579 | 1,741 | 71 | 1.43 | $1,325,632 | $146,995 |
| 2013 | 515 | 1,416 | 71 | 1.50 | $1,073,477 | $120,721 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Insertion of inflatable urethra or bladder neck sphincter | 25 | $17,064 | $683 |
| Insertion of multicomponent inflatable penile implant | 17 | $12,853 | $714 |
| Short return visit (20+ min) | 177 | $12,269 | $54 |
| Reconstruction or repair of urethra | 11 | $11,047 | $1,004 |
| Return visit (30+ min) | 115 | $10,552 | $84 |
| Diagnostic exam of bladder and urethra using an endoscope | 126 | $8,703 | $66 |
| New patient visit (45+ min) | 52 | $5,457 | $105 |
| Incision of urethra using an endoscope | 24 | $5,316 | $221 |
| New patient visit (30+ min) | 60 | $4,071 | $68 |
| Injection procedure through bladder and urethra for x-ray imaging | 21 | $909 | $43 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $891 | $45 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $517 | $7 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $347 | $23 |
| Review by radiologist of urinary bladder and urethra images with contrast | 21 | $300 | $14 |
| Injection procedure for imaging of bladder during voiding | 12 | $269 | $22 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 11 | $156 | $14 |
| Electronic assessment of bladder emptying | 11 | $52 | $5 |
2022: 14 services
| Reconstruction or repair of urethra | 14 | $13,934 | $995 |
| Insertion of inflatable urethra or bladder neck sphincter | 20 | $13,578 | $679 |
| Return visit (30+ min) | 127 | $10,861 | $79 |
| Short return visit (20+ min) | 154 | $9,678 | $50 |
| Diagnostic exam of bladder and urethra using an endoscope | 129 | $8,148 | $58 |
| New patient visit (45+ min) | 47 | $4,311 | $92 |
| Incision of urethra using an endoscope | 14 | $3,205 | $229 |
| New patient visit (30+ min) | 45 | $2,958 | $66 |
| Biopsy of prostate gland | 24 | $2,484 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,415 | $57 |
| Injection procedure through bladder and urethra for x-ray imaging | 33 | $1,216 | $37 |
| Ultrasound scan of pelvic region through rectum | 24 | $615 | $26 |
| Review by radiologist of urinary bladder and urethra images with contrast | 33 | $441 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $375 | $8 |
2021: 24 services
| Return visit (30+ min) | 141 | $14,423 | $88 |
| Reconstruction or repair of urethra | 12 | $13,359 | $1,028 |
| Insertion of inflatable urethra or bladder neck sphincter | 19 | $13,235 | $697 |
| Diagnostic exam of bladder and urethra using an endoscope | 161 | $11,479 | $64 |
| New patient visit (45+ min) | 82 | $9,891 | $121 |
| Short return visit (20+ min) | 139 | $9,307 | $54 |
| Insertion of multicomponent inflatable penile implant | 12 | $8,870 | $739 |
| Long return visit (40+ min) | 53 | $7,513 | $127 |
| Incision of urethra using an endoscope | 15 | $3,707 | $218 |
| Biopsy of prostate gland | 26 | $2,803 | $108 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $2,426 | $135 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $2,077 | $90 |
| New patient visit (30+ min) | 27 | $1,965 | $73 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $1,351 | $113 |
| Injection procedure through bladder and urethra for x-ray imaging | 32 | $1,212 | $37 |
| Ultrasound scan of pelvic region through rectum | 29 | $868 | $30 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $731 | $49 |
| Injection procedure for imaging of bladder during voiding | 25 | $687 | $27 |
| Short return visit | 17 | $589 | $33 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $423 | $35 |
| Review by radiologist of urinary bladder and urethra images with contrast | 31 | $412 | $13 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 28 | $383 | $14 |
| Simple insertion of temporary bladder tube | 14 | $380 | $22 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $234 | $18 |
2020: 22 services
| Insertion of inflatable urethra or bladder neck sphincter | 19 | $14,191 | $710 |
| Diagnostic exam of bladder and urethra using an endoscope | 127 | $8,602 | $63 |
| Removal and replacement of inflatable urethra or bladder neck sphincter | 11 | $8,400 | $764 |
| Short return visit (20+ min) | 131 | $7,500 | $45 |
| Return visit (30+ min) | 88 | $6,816 | $68 |
| New patient visit (45+ min) | 54 | $5,951 | $110 |
| New patient visit (30+ min) | 52 | $3,455 | $66 |
| Biopsy of prostate gland | 17 | $1,900 | $106 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 16 | $1,636 | $102 |
| Injection procedure through bladder and urethra for x-ray imaging | 29 | $1,193 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,106 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,091 | $73 |
| Long return visit (40+ min) | 14 | $1,041 | $74 |
| Simple change of bladder tube | 14 | $909 | $45 |
| Injection procedure for imaging of bladder during voiding | 28 | $814 | $27 |
| Simple insertion of temporary bladder tube | 22 | $739 | $22 |
| Insertion of device into abdomen with pressure and urine flow rate study | 16 | $575 | $36 |
| Ultrasound scan of pelvic region through rectum | 17 | $493 | $27 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 30 | $453 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast | 27 | $379 | $14 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $326 | $23 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 17 | $280 | $16 |
2019: 20 services
| Reconstruction or repair of urethra | 11 | $11,391 | $1,036 |
| Diagnostic exam of bladder and urethra using an endoscope | 161 | $10,949 | $64 |
| Insertion of inflatable urethra or bladder neck sphincter | 13 | $9,776 | $698 |
| Short return visit (20+ min) | 134 | $6,582 | $40 |
| New patient visit (45+ min) | 50 | $5,177 | $104 |
| Long return visit (40+ min) | 52 | $4,659 | $90 |
| Return visit (30+ min) | 56 | $3,530 | $61 |
| Incision of urethra using an endoscope | 13 | $3,105 | $222 |
| New patient visit (30+ min) | 40 | $2,700 | $68 |
| Biopsy of prostate gland | 18 | $2,022 | $106 |
| Injection procedure through bladder and urethra for x-ray imaging | 44 | $1,909 | $43 |
| Simple change of bladder tube | 20 | $1,843 | $40 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $1,770 | $126 |
| Injection procedure for imaging of bladder during voiding | 24 | $846 | $33 |
| Simple insertion of temporary bladder tube | 17 | $747 | $22 |
| Simple bladder irrigation and/or instillation | 20 | $678 | $26 |
| Ultrasound scan of pelvic region through rectum | 18 | $573 | $30 |
| Review by radiologist of urinary bladder and urethra images with contrast | 40 | $569 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 28 | $433 | $14 |
| Electronic assessment of bladder emptying | 46 | $252 | $5 |
2018: 20 services
| Insertion of inflatable urethra or bladder neck sphincter | 25 | $17,030 | $681 |
| Reconstruction or repair of urethra | 14 | $14,306 | $1,022 |
| Diagnostic exam of bladder and urethra using an endoscope | 173 | $12,513 | $67 |
| Reconstruction of urethra in male | 12 | $10,484 | $874 |
| Short return visit (20+ min) | 169 | $9,674 | $41 |
| New patient visit (45+ min) | 64 | $7,251 | $113 |
| Long return visit (40+ min) | 57 | $5,379 | $94 |
| Incision of urethra using an endoscope | 16 | $4,521 | $238 |
| Return visit (30+ min) | 54 | $3,962 | $67 |
| Simple change of bladder tube | 19 | $3,187 | $42 |
| Injection procedure through bladder and urethra for x-ray imaging | 54 | $2,352 | $44 |
| New patient visit (30+ min) | 34 | $2,085 | $61 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 13 | $1,027 | $79 |
| Injection procedure for imaging of bladder during voiding | 31 | $888 | $28 |
| Review by radiologist of urinary bladder and urethra images with contrast | 51 | $690 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 35 | $527 | $15 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $462 | $36 |
| Simple bladder irrigation and/or instillation | 16 | $421 | $25 |
| Electronic assessment of bladder emptying | 62 | $376 | $6 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $195 | $15 |
2017: 21 services
| Diagnostic exam of bladder and urethra using an endoscope | 166 | $13,929 | $79 |
| Insertion of inflatable urethra or bladder neck sphincter | 22 | $13,894 | $632 |
| New patient visit (45+ min) | 110 | $10,991 | $100 |
| Reconstruction or repair of urethra | 11 | $10,930 | $994 |
| Short return visit (20+ min) | 197 | $9,675 | $40 |
| Return visit (30+ min) | 76 | $4,997 | $59 |
| Long return visit (40+ min) | 49 | $4,484 | $92 |
| Incision of urethra using an endoscope | 18 | $3,796 | $200 |
| New patient visit (30+ min) | 50 | $3,156 | $63 |
| Simple change of bladder tube | 13 | $2,978 | $43 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 19 | $1,993 | $105 |
| Injection procedure through bladder and urethra for x-ray imaging | 42 | $1,809 | $43 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 11 | $1,494 | $136 |
| Simple bladder irrigation and/or instillation | 26 | $778 | $28 |
| Insertion of device into abdomen with pressure and urine flow rate study | 18 | $632 | $35 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 37 | $503 | $13 |
| Review by radiologist of urinary bladder and urethra images with contrast | 35 | $489 | $14 |
| Injection procedure for imaging of bladder during voiding | 25 | $464 | $19 |
| Electronic assessment of bladder emptying | 83 | $451 | $5 |
| Simple insertion of temporary bladder tube | 12 | $420 | $19 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 15 | $252 | $17 |
2016: 23 services
| Diagnostic exam of bladder and urethra using an endoscope | 191 | $21,965 | $101 |
| Reconstruction or repair of urethra | 13 | $13,187 | $1,014 |
| New patient visit (45+ min) | 118 | $12,026 | $102 |
| Reconstruction of urethra in male | 15 | $11,954 | $797 |
| Insertion of inflatable urethra or bladder neck sphincter | 18 | $11,519 | $640 |
| Short return visit (20+ min) | 214 | $11,207 | $39 |
| Return visit (30+ min) | 69 | $4,746 | $65 |
| Simple change of bladder tube | 13 | $3,056 | $44 |
| Incision of urethra using an endoscope | 14 | $2,919 | $195 |
| Biopsy of prostate gland | 21 | $2,789 | $121 |
| New patient visit (30+ min) | 36 | $2,258 | $63 |
| Injection procedure through bladder and urethra for x-ray imaging | 39 | $1,746 | $44 |
| Injection procedure for imaging of bladder during voiding | 44 | $1,670 | $33 |
| Simple bladder irrigation and/or instillation | 28 | $1,062 | $35 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 53 | $869 | $14 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $735 | $67 |
| Ultrasound scan of pelvic region through rectum | 21 | $644 | $29 |
| Electronic assessment of bladder emptying | 97 | $610 | $6 |
| Review by radiologist of urinary bladder and urethra images with contrast | 38 | $547 | $14 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $498 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $409 | $34 |
| Short return visit | 12 | $267 | $21 |
| Imaging of urinary tract following injection of a contrast agent | 15 | $264 | $16 |
2015: 19 services
| Diagnostic exam of bladder and urethra using an endoscope | 153 | $16,709 | $99 |
| Reconstruction of urethra in male | 14 | $11,030 | $788 |
| New patient visit (45+ min) | 98 | $10,759 | $110 |
| Short return visit (20+ min) | 178 | $10,444 | $41 |
| Return visit (30+ min) | 123 | $8,409 | $61 |
| Insertion of inflatable urethra or bladder neck sphincter | 12 | $8,221 | $685 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 11 | $3,265 | $297 |
| Incision of urethra using an endoscope | 13 | $2,938 | $226 |
| Simple change of bladder tube | 12 | $2,409 | $42 |
| New patient visit (30+ min) | 33 | $1,891 | $57 |
| Injection procedure for imaging of bladder during voiding | 61 | $1,871 | $30 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 19 | $1,189 | $63 |
| Injection procedure through bladder and urethra for x-ray imaging | 22 | $1,169 | $49 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 69 | $1,090 | $14 |
| Simple bladder irrigation and/or instillation | 22 | $933 | $39 |
| Insertion of device into abdomen with pressure and urine flow rate study | 21 | $712 | $34 |
| Electronic assessment of bladder emptying | 94 | $659 | $6 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 15 | $514 | $34 |
| Review by radiologist of urinary bladder and urethra images with contrast | 17 | $252 | $14 |
2014: 24 services
| Diagnostic exam of bladder and urethra using an endoscope | 186 | $22,239 | $105 |
| Return visit (30+ min) | 169 | $13,613 | $65 |
| New patient visit (45+ min) | 100 | $10,559 | $106 |
| Short return visit (20+ min) | 172 | $9,040 | $42 |
| New patient visit (30+ min) | 67 | $4,138 | $62 |
| Incision of urethra using an endoscope | 16 | $3,698 | $218 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $2,631 | $125 |
| Biopsy of prostate gland | 24 | $2,318 | $97 |
| Insertion of lower leg neurostimulator electrode | 12 | $2,207 | $25 |
| Dilation of urethra using an endoscope | 16 | $2,092 | $105 |
| Simple change of bladder tube | 12 | $2,059 | $43 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 28 | $2,054 | $73 |
| Injection procedure for imaging of bladder during voiding | 47 | $1,309 | $27 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 32 | $1,172 | $37 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 68 | $1,032 | $15 |
| Insertion of device into abdomen with pressure and urine flow rate study | 28 | $998 | $36 |
| Simple bladder irrigation and/or instillation | 19 | $991 | $40 |
| Electronic assessment of bladder emptying | 131 | $949 | $6 |
| Ultrasound scan of pelvic region through rectum | 24 | $736 | $31 |
| Ultrasonic guidance for needle placement | 24 | $721 | $30 |
| Injection procedure through bladder and urethra for x-ray imaging | 19 | $687 | $34 |
| Review by radiologist of urinary bladder and urethra images with contrast | 25 | $389 | $14 |
| Short return visit | 15 | $325 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $83 | $7 |
2013: 22 services
| Diagnostic exam of bladder and urethra using an endoscope | 156 | $18,012 | $105 |
| Return visit (30+ min) | 166 | $12,446 | $62 |
| New patient visit (45+ min) | 77 | $8,195 | $106 |
| Short return visit (20+ min) | 150 | $8,094 | $42 |
| New patient visit (30+ min) | 80 | $4,790 | $60 |
| Biopsy of prostate gland | 16 | $1,679 | $105 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 27 | $1,657 | $59 |
| Simple bladder irrigation and/or instillation | 34 | $1,634 | $38 |
| Dilation of urethra using an endoscope | 11 | $1,462 | $133 |
| Simple change of bladder tube | 13 | $1,361 | $41 |
| Injection procedure for imaging of bladder during voiding | 34 | $884 | $25 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 23 | $795 | $33 |
| Simple insertion of temporary bladder tube | 14 | $731 | $26 |
| Insertion of device into abdomen with pressure and urine flow rate study | 19 | $693 | $35 |
| Electronic assessment of bladder emptying | 98 | $668 | $6 |
| Injection procedure through bladder and urethra for x-ray imaging | 17 | $665 | $39 |
| New patient visit (15+ min) | 21 | $560 | $27 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 40 | $559 | $14 |
| Ultrasound scan of pelvic region through rectum | 15 | $435 | $29 |
| Ultrasonic guidance for needle placement | 15 | $432 | $29 |
| Review by radiologist of urinary bladder and urethra images with contrast | 17 | $242 | $14 |
| Short return visit | 11 | $217 | $20 |
Medicaid work
$1,410 in 2024
Medicaid paid $1,410 for 15 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $1,410 |
| 2024 | 15 | 1 | 14 | $1,410 |
| 2023 | 112 | 5 | 21 | $4,198 |
| 2022 | 63 | 4 | 24 | $3,839 |
| 2021 | 333 | 5 | 26 | $3,548 |
| 2020 | 238 | 8 | 25 | $2,811 |
| 2019 | 221 | 5 | 21 | $1,236 |
| 2018 | 107 | 2 | 19 | $1,241 |
See the largest Medicaid services in earlier years
2023
| Service | 31 | $2,063 |
| CYSTOURETHROSCOPY | 15 | $1,067 |
| Return visit (30+ min) | 14 | $604 |
| Short return visit (20+ min) | 37 | $339 |
| Telehealth transmission, per minute, professional services bill separately | 15 | $125 |
2022
| Hospital outpatient clinic visit for assessment and management of a patient | 12 | $3,160 |
| CYSTOURETHROSCOPY | 12 | $363 |
| Service | 24 | $266 |
| Short return visit (20+ min) | 15 | $49 |
2021
| CYSTOURETHROSCOPY | 121 | $3,427 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 20 | $121 |
| Service | 30 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 15 | $0 |
| Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 147 | $0 |
2020
| CYSTOURETHROSCOPY | 55 | $1,161 |
| TISSUE EXAM BY PATHOLOGIST | 16 | $778 |
| Short return visit (20+ min) | 12 | $630 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 39 | $242 |
| Service | 19 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 12 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 12 | $0 |
| Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 73 | $0 |
2019
| CYSTOURETHROSCOPY | 91 | $1,166 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 19 | $61 |
| OFF/OP EST MAY X REQ PHY/QHP | 61 | $8 |
| Hospital outpatient clinic visit for assessment and management of a patient | 31 | $0 |
| Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 19 | $0 |
2018
| CYSTOURETHROSCOPY | 93 | $830 |
| Short return visit (20+ min) | 14 | $411 |
Drugs they prescribed that Part D paid
$68,019
Pharmacies billed $68,019 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
288 generic and fewer than 11 brand-name prescriptions · $68,019 in drug cost · 69 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 50 | $40,641 | $813 |
| Gemtesa | 28 | $19,202 | $686 |
| Methenamine Hippurate | 39 | $1,285 | $33 |
| Imipramine | 38 | $1,133 | $30 |
| Tamsulosin | 50 | $818 | $16 |
See all 8 drugs
| Myrbetriq | 50 | $40,641 | $813 |
| Gemtesa | 28 | $19,202 | $686 |
| Methenamine Hippurate | 39 | $1,285 | $33 |
| Imipramine | 38 | $1,133 | $30 |
| Tamsulosin | 50 | $818 | $16 |
| Finasteride | 24 | $402 | $17 |
| Terazosin | 12 | $367 | $31 |
| Sulfamethoxazole-Trimethoprim | 43 | $225 | $5 |
Year by year
| 2024 | 367 | 169 | None | None | $68,019 |
| 2023 | 517 | 203 | None | 17% | $94,227 |
| 2022 | 585 | 204 | None | 15% | $68,690 |
| 2021 | 866 | 263 | None | None | $53,004 |
| 2020 | 954 | 281 | 2% (16) | None | $55,248 |
| 2019 | 998 | 242 | 2% (20) | None | $73,623 |
| 2018 | 1,010 | 231 | 2% (19) | None | $71,762 |
| 2017 | 1,072 | 260 | 2% (18) | None | $81,268 |
| 2016 | 1,163 | 270 | 5% (57) | None | $70,837 |
| 2015 | 1,077 | 243 | 4% (43) | None | $64,622 |
| 2014 | 807 | 221 | 7% (53) | 10% | $41,399 |
| 2013 | 567 | 172 | 5% (28) | 10% | $30,009 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Myrbetriq | 84 | $77,214 | $919 |
| Methenamine Hippurate | 48 | $5,433 | $113 |
| Tamsulosin | 84 | $2,587 | $31 |
| Finasteride | 75 | $1,417 | $19 |
| Imipramine | 31 | $1,093 | $35 |
| Terazosin | 37 | $832 | $22 |
| Oxybutynin Chloride Er | 16 | $510 | $32 |
| Sulfamethoxazole-Trimethoprim | 52 | $320 | $6 |
2022: 9 drugs
| Myrbetriq | 53 | $47,987 | $905 |
| Methenamine Hippurate | 70 | $6,797 | $97 |
| Tamsulosin | 132 | $2,759 | $21 |
| Oxybutynin Chloride Er | 48 | $1,690 | $35 |
| Imipramine | 50 | $1,517 | $30 |
| Finasteride | 79 | $1,205 | $15 |
| Alfuzosin Hcl Er | 16 | $642 | $40 |
| Terazosin | 19 | $432 | $23 |
| Sulfamethoxazole-Trimethoprim | 24 | $147 | $6 |
2021: 13 drugs
| Myrbetriq | 59 | $28,920 | $490 |
| Methenamine Hippurate | 64 | $5,327 | $83 |
| Tamsulosin | 248 | $3,722 | $15 |
| Oxybutynin Chloride Er | 82 | $2,988 | $36 |
| Tolterodine Tartrate Er | 14 | $2,468 | $176 |
| Finasteride | 98 | $1,250 | $13 |
| Imipramine | 59 | $1,215 | $21 |
| Oxybutynin Chloride | 41 | $919 | $22 |
| Terazosin | 27 | $405 | $15 |
| Alfuzosin Hcl Er | 12 | $387 | $32 |
| Sulfamethoxazole-Trimethoprim | 28 | $104 | $4 |
| Ibuprofen | 18 | $87 | $5 |
| Ciprofloxacin | 12 | $87 | $7 |
2020: 16 drugs
| Myrbetriq | 28 | $19,128 | $683 |
| Tolterodine Tartrate Er | 39 | $5,829 | $149 |
| Methenamine Hippurate | 60 | $5,284 | $88 |
| Tamsulosin | 283 | $4,134 | $15 |
| Tadalafil | 27 | $3,574 | $132 |
| Oxybutynin Chloride | 57 | $2,219 | $39 |
| Oxybutynin Chloride Er | 42 | $1,859 | $44 |
| Finasteride | 95 | $1,322 | $14 |
| Imipramine | 55 | $1,103 | $20 |
| Nitrofurantoin Mono-Macro | 18 | $715 | $40 |
| Alfuzosin Hcl Er | 13 | $488 | $38 |
| Terazosin | 24 | $453 | $19 |
| Sulfamethoxazole-Trimethoprim | 60 | $243 | $4 |
| Ibuprofen | 22 | $226 | $10 |
| Ciprofloxacin | 14 | $84 | $6 |
| Cephalexin | 14 | $62 | $4 |
2019: 16 drugs
| Myrbetriq | 30 | $22,296 | $743 |
| Tadalafil | 32 | $7,890 | $247 |
| Tolterodine Tartrate Er | 34 | $6,444 | $190 |
| Methenamine Hippurate | 43 | $6,082 | $141 |
| Tamsulosin | 333 | $5,603 | $17 |
| Oxybutynin Chloride | 77 | $3,213 | $42 |
| Finasteride | 88 | $1,855 | $21 |
| Oxybutynin Chloride Er | 29 | $1,775 | $61 |
| Imipramine | 34 | $824 | $24 |
| Clobetasol Propionate | 11 | $790 | $72 |
| Dutasteride | 20 | $678 | $34 |
| Terazosin | 37 | $643 | $17 |
| Alfuzosin Hcl Er | 11 | $501 | $46 |
| Doxazosin Mesylate | 13 | $236 | $18 |
| Sulfamethoxazole-Trimethoprim | 40 | $180 | $5 |
| Ciprofloxacin | 11 | $74 | $7 |
2018: 19 drugs
| Myrbetriq | 41 | $18,140 | $442 |
| Cialis | 23 | $10,371 | $451 |
| Tolterodine Tartrate Er | 32 | $8,558 | $267 |
| Tamsulosin | 303 | $7,552 | $25 |
| Oxybutynin Chloride | 99 | $4,621 | $47 |
| Methenamine Hippurate | 43 | $4,586 | $107 |
| Rapaflo | 15 | $3,705 | $247 |
| Oxybutynin Chloride Er | 27 | $1,948 | $72 |
| Finasteride | 79 | $1,636 | $21 |
| Clobetasol Propionate | 12 | $1,322 | $110 |
| Dutasteride | 13 | $1,044 | $80 |
| Imipramine | 57 | $985 | $17 |
| Trospium Chloride | 12 | $802 | $67 |
| Alfuzosin Hcl Er | 20 | $797 | $40 |
| Terazosin | 47 | $714 | $15 |
| Polyethylene Glycol 3350 | 32 | $595 | $19 |
| Sulfamethoxazole-Trimethoprim | 42 | $187 | $4 |
| Pentoxifylline | 12 | $150 | $12 |
| Cephalexin | 17 | $82 | $5 |
2017: 18 drugs
| Myrbetriq | 43 | $16,647 | $387 |
| Tolterodine Tartrate Er | 53 | $11,687 | $221 |
| Tamsulosin | 294 | $8,423 | $29 |
| Cialis | 14 | $6,739 | $481 |
| Oxybutynin Chloride | 131 | $5,916 | $45 |
| Methenamine Hippurate | 41 | $4,358 | $106 |
| Rapaflo | 17 | $3,791 | $223 |
| Potassium Citrate Er | 12 | $2,167 | $181 |
| Finasteride | 114 | $2,016 | $18 |
| Oxybutynin Chloride Er | 18 | $1,965 | $109 |
| Desmopressin Acetate | 13 | $811 | $62 |
| Nitrofurantoin Mono-Macro | 26 | $655 | $25 |
| Polyethylene Glycol 3350 | 30 | $650 | $22 |
| Imipramine | 61 | $634 | $10 |
| Terazosin | 37 | $527 | $14 |
| Alfuzosin Hcl Er | 23 | $485 | $21 |
| Sulfamethoxazole-Trimethoprim | 33 | $145 | $4 |
| Cephalexin | 17 | $75 | $4 |
2016: 20 drugs
| Myrbetriq | 34 | $13,166 | $387 |
| Tolterodine Tartrate Er | 48 | $9,835 | $205 |
| Tamsulosin | 306 | $9,461 | $31 |
| Oxybutynin Chloride | 121 | $4,994 | $41 |
| Finasteride | 157 | $2,864 | $18 |
| Rapaflo | 11 | $2,300 | $209 |
| Methenamine Hippurate | 14 | $2,009 | $144 |
| Nitrofurantoin Mono-Macro | 42 | $1,843 | $44 |
| Dutasteride | 13 | $1,089 | $84 |
| Oxybutynin Chloride Er | 15 | $987 | $66 |
| Polyethylene Glycol 3350 | 31 | $965 | $31 |
| Desmopressin Acetate | 16 | $909 | $57 |
| Terazosin | 55 | $786 | $14 |
| Imipramine | 25 | $622 | $25 |
| Hydrocodone-Acetaminophen | 26 | $613 | $24 |
| Alfuzosin Hcl Er | 11 | $345 | $31 |
| Oxycodone | 26 | $342 | $13 |
| Cephalexin | 35 | $326 | $9 |
| Ciprofloxacin | 31 | $301 | $10 |
| Sulfamethoxazole-Trimethoprim | 31 | $111 | $4 |
2015: 18 drugs
| Tamsulosin | 311 | $9,617 | $31 |
| Tolterodine Tartrate Er | 38 | $9,567 | $252 |
| Myrbetriq | 18 | $7,000 | $389 |
| Androgel | 11 | $5,100 | $464 |
| Nitrofurantoin Mono-Macro | 50 | $3,707 | $74 |
| Oxybutynin Chloride | 91 | $2,927 | $32 |
| Finasteride | 156 | $2,436 | $16 |
| Oxybutynin Chloride Er | 30 | $2,425 | $81 |
| Polyethylene Glycol 3350 | 22 | $477 | $22 |
| Imipramine | 19 | $472 | $25 |
| Terazosin | 33 | $421 | $13 |
| Hydrocodone-Acetaminophen | 16 | $322 | $20 |
| Cephalexin | 34 | $264 | $8 |
| Alfuzosin Hcl Er | 11 | $253 | $23 |
| Ciprofloxacin | 25 | $216 | $9 |
| Oxycodone | 18 | $211 | $12 |
| Nystatin | 12 | $180 | $15 |
| Sulfamethoxazole-Trimethoprim | 25 | $163 | $7 |
2014: 15 drugs
| Tamsulosin | 197 | $4,175 | $21 |
| Nitrofurantoin Mono-Macro | 32 | $2,956 | $92 |
| Oxybutynin Chloride | 90 | $2,941 | $33 |
| Finasteride | 102 | $2,345 | $23 |
| Toviaz | 12 | $2,279 | $190 |
| Cialis | 12 | $2,188 | $182 |
| Potassium Citrate Er | 13 | $2,150 | $165 |
| Polyethylene Glycol 3350 | 26 | $879 | $34 |
| Imipramine | 29 | $684 | $24 |
| Nystatin | 21 | $447 | $21 |
| Terazosin | 26 | $393 | $15 |
| Hydrocodone-Acetaminophen | 37 | $332 | $9 |
| Sulfamethoxazole-Trimethoprim | 29 | $218 | $8 |
| Ciprofloxacin | 33 | $192 | $6 |
| Cephalexin | 16 | $169 | $11 |
2013: 12 drugs
| Finasteride | 71 | $3,037 | $43 |
| Tamsulosin | 111 | $2,809 | $25 |
| Nitrofurantoin Mono-Macro | 20 | $2,370 | $119 |
| Oxybutynin Chloride Er | 25 | $2,341 | $94 |
| Oxybutynin Chloride | 85 | $1,797 | $21 |
| Potassium Citrate | 13 | $1,423 | $109 |
| Trospium Chloride | 11 | $1,215 | $110 |
| Imipramine | 20 | $449 | $22 |
| Terazosin | 33 | $428 | $13 |
| Sulfamethoxazole-Trimethoprim | 20 | $183 | $9 |
| Ciprofloxacin | 27 | $160 | $6 |
| Hydrocodone-Acetaminophen | 19 | $138 | $7 |
Money from drug and device companies
$15,170 in 2025
| 2025 | 4 | 19 | $12,370 | $15,170 |
| 2024 | 1 | 2 | None | $264 |
| 2023 | 2 | 13 | $3,538 | $3,931 |
| 2022 | 3 | 19 | $14,951 | $16,745 |
| 2021 | 2 | 6 | $2,750 | $3,115 |
| 2020 | 1 | 1 | None | $84 |
| 2019 | 1 | 3 | None | $236 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Endo USA | Xiaflex | $13,061 | 10 payments
|
| LEO Pharma AS | None | $1,690 | 1 payment
|
| Boston Scientific | Ams 700 | $270 | 7 payments
|
| Medtronic | Interstim | $148 | 1 payment
|
See all 19 published payments
| Medtronic | Meals · 2025-12-22 | Interstim | $148 |
| Boston Scientific | Meals · 2025-11-17 | Ams 700 | $6 |
| Boston Scientific | Meals · 2025-08-20 | Ams 800 Artificial Urinary Sphincter | $32 |
| LEO Pharma AS | Consulting · 2025-07-29 | None | $1,690 |
| Endo USA | Consulting · 2025-05-21 | Xiaflex | $10,680 |
| Endo USA | Travel · 2025-05-21 | Xiaflex | $53 |
| Endo USA | Travel · 2025-05-03 | Xiaflex | $40 |
| Endo USA | Meals · 2025-05-03 | Xiaflex | $56 |
| Endo USA | Travel · 2025-05-03 | Xiaflex | $1,194 |
| Endo USA | Meals · 2025-05-03 | Xiaflex | $45 |
| Endo USA | Meals · 2025-05-03 | Xiaflex | $46 |
| Endo USA | Travel · 2025-05-03 | Xiaflex | $558 |
| Endo USA | Travel · 2025-05-02 | Xiaflex | $255 |
| Endo USA | Meals · 2025-05-02 | Xiaflex | $134 |
| Boston Scientific | Meals · 2025-04-28 | General - Therapies | $35 |
| Boston Scientific | Meals · 2025-04-15 | Ams 700 | $24 |
| Boston Scientific | Meals · 2025-04-04 | Ams 700 | $87 |
| Boston Scientific | Meals · 2025-02-03 | Ams 700 | $22 |
| Boston Scientific | Meals · 2025-01-11 | Ams 800 Artificial Urinary Sphincter | $65 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $264
| Boston Scientific | Ams 700 | $264 | 2 payments
|
2023: $3,931
| Boston Scientific | Tactra | $2,894 | 12 payments
|
| Sanofi-Aventis U.S. | None | $1,038 | 1 payment
|
2022: $16,745
| Sanofi-Aventis U.S. | None | $7,728 | 3 payments
|
| Boston Scientific | General - Erectile Dysfunction | $6,784 | 13 payments
|
| Coloplast | Porges Coloplast | $2,233 | 3 payments
|
2021: $3,115
| Boston Scientific | Advance | $3,040 | 5 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $75 | 1 payment
|
2020: $84
| Boston Scientific | Ams | $84 | 1 payment
|
2019: $236
| Boston Scientific | General Therapies | $236 | 3 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boston Scientific Corporation · Ausco · 2023 | Their institution | $16,122 |
| Boston Scientific Corporation · Ausco · 2021 | Their institution | $13,231 |
| Boston Scientific Corporation · Ausco · 2024 | Their institution | $13,048 |
| BOSTON SCIENTIFIC CORPORATION · Ausco · 2022 | Their institution | $5,488 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1316160211
- Licence
- CA A91487California A91487: Current · expires 2028-11-30
- Trained
- University of Chicago, Pritzker School of Medicine, 2003 · 23 years ago
- Group
- UCSF Medical Group Business Services · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 850 Stanyan St Apt 5, San Francisco, CA, 94117
- NPI first listed
- 2007-04-10
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.